Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | OBK | QCRH |
|---|---|---|
| Price | $53.12 | $100.03 |
| Change today | ▼ 0.93% | ▼ 0.91% |
| Market cap | $1.64B | $1.64B |
| Return, 3 months | +4.0% | +4.5% |
| Return, year to date | +43.1% | +20.5% |
| Return, 1 year | +54.9% | +32.1% |
| P/E (TTM) | 16.7 | 11.8 |
| P/B | 1.3 | 1.4 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 1.32% | 0.32% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +9.2% | +10.6% |
| Analyst buy share | 67% | 60% |
| RSI (14) | 48 | 48 |
| 30-day volatility | 14.3% | 15.2% |
| Max drawdown, 1 year | -12.2% | -15.3% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
